Dr. Mark "Marty" Pagel has focused on molecular imaging research during the last 20 years in industry and academia. He is a Professor in the Departments of Cancer Systems Imaging and Imaging Physics at the University of Texas MD Anderson Cancer Center. In addition, Dr. Pagel has held leadership positions in professional societies, funding agencies, and scientific journals that focus on molecular imaging. Dr. Pagel’s current research focuses on CEST MRI, DCE MRI, PET/MRI, photoacoustic imaging, fluorescence guided surgery, and EPR imaging for studies with mouse models of cancer and for clinical trials with cancer patients. He uses these imaging modalities to interrogate biomarkers of the tumor microenvironment, including acidosis, hypoxia, vascular perfusion and enzyme activity.